This topic contains a solution. Click here to go to the answer

Author Question: The nurse recognizes that respiratory depression is a risk with some cough suppressants. Which ... (Read 60 times)

CQXA

  • Hero Member
  • *****
  • Posts: 546
The nurse recognizes that respiratory depression is a risk with some cough suppressants. Which preparation has the least risk of causing respiratory depression?
 
  1. Codeine-based
  2. Codeine with bromodiphenhydramin e (Ambenyl)
  3. Hydrocodone with homatropine (Hycodan)
  4. Dextromethorphan (Delsym)

Question 2

A client is receiving a phenylephrine (Afrin) nasal spray for the symptoms of a cold. Which assessment parameter would the nurse expect to see improved?
 
  1. A decrease in nasal stuffiness
  2. Improved energy level
  3. Less coughing
  4. Fewer nasal secretions



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Pariscourtney

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

Correct Answer: 4
Rationale 1: Codeine is a narcotic, and even low-dose preparations have the potential for respiratory depression, particularly if attention is not directed toward proper dosing.
Rationale 2: Codeine is a narcotic, and even low-dose preparations like Ambenyl have the potential for respiratory depression, particularly if attention is not directed toward proper dosing.
Rationale 3: Hycodan (with the narcotic hydrocodone) has a greater potential for respiratory depression than another cough suppressant.
Rationale 4: Delsym (dextromethorphan) is a nonnarcotic preparation with the lowest potential for respiratory depression.
Global Rationale: There are almost no adverse effects at therapeutic doses of dextromethorphan. Sedation and dizziness have occurred at moderate doses. In abuse situations the drug can cause CNS toxicity with a wide variety of symptoms, including slurred speech, ataxia, hyperexcitability, stupor, respiratory depression, seizures, coma, and toxic psychosis. The remaining products are all narcotic-based with risk for respiratory depression.

Answer to Question 2

Correct Answer: 1
Rationale 1: Phenylephrine is a decongestant topical preparation that decreases puffiness of the mucous membranes inside the nose. Subjectively, the client will experience less stuffiness.
Rationale 2: Energy levels will improve as the cold subsides; there is no medication that assists with that symptom.
Rationale 3: The client will still have posterior pharyngeal irritation with coughing.
Rationale 4: An antihistamine decreases the quantity of secretions.
Global Rationale: Sympathomimetics (also called adrenergic agonists) with alpha-adrenergic activity are effective at relieving the nasal congestion associated with the common cold and allergic rhinitis when given by either the PO or intranasal route. The intranasal preparations such as oxymetazoline (Afrin, Others) are available OTC as sprays or drops and produce a noticeable response within minutes. Energy levels will improve as the cold subsides; there is no medication that assists with that symptom. The client will still have posterior pharyngeal irritation with coughing. An antihistamine decreases the quantity of secretions.




CQXA

  • Member
  • Posts: 546
Reply 2 on: Jul 23, 2018
:D TYSM


gcook

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Gracias!

 

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

For a complete list of videos, visit our video library